Hans Brons New CEO Enzyre

April 1, 2024, Nijmegen, Netherlands: Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, announces today the appointment of Hans Brons as Chief Executive Officer.

Enzyre, a spin-out from Radboud University Medical Center in The Netherlands, started by Waander van Heerde and Guido Maertens, develops an innovative near patient microfluidic platform technology to measure biomarkers in just a few drops of blood. Near patient diagnostic tools are crucial for early diagnosis and offers the flexibility to allow disease management by personalized medicine in the home or critical care setting. Enzyre’s platform technology aims to revolutionize the diagnosis and treatment of multiple thrombotic and hemostatic disorders by providing a real-time picture of a patient’s blood coagulation status.

Marcel van Kasteel, Chairman of Enzyre’s Supervisory Board, said: “We are delighted to have Hans Brons joining the team as CEO. He brings a successful track record and 20 years of experience in the development and commercialization of (Med)Tech startup and scaleup companies. We are also grateful to Roald van Noort and Joop Kersten, who did a tremendous job during the last six months as interim CEO and CFO.”

Hans Brons, newly-appointed CEO of Enzyre, added: “I’m very pleased to join a great team with an outstanding technology that offers tremendous potential to allow patients and healthcare professionals to manage disease in real time.”

Hans Brons is a business leader with more than 30 years of industry experience. and a passion for fast-growing technology-based start-up and scale-up companies. Hans led Nemo Healthcare BV and Medis Medical Imaging Systems BV. Even before, Hans served as CEO/Founder of IREX Technologies BV and IRX Innovations BV and held various leadership roles at Philips Electronics NV and at AT&T Network Systems BV for ten and four years, respectively. Hans obtained his MSc degree in Economics from the University of Tilburg (NL) and his MBA degree from Bradford University (UK).

For more information about Enzyre and its products, please visit the company’s website at www.enzyre.com.